Webinar - The Role of LAIs in the Management of Schizophrenia (Christoph Correll, MD) 

The Role of Long-Acting Antipsychotics in the Management of Schizophrenia presented by Christoph Correll, MD on December 13, 2017.
This webinar recording provided information about the problem of relapses for outcomes in people with schizophrenia, discussed the potential role and value of long-acting-injectable antipsychotics in the management of schizophrenia. Reasons for relapse and for failing to achieve remission and recovery was outlined, including the relevance and frequency of non-adherence. Characteristics of different long-acting-injectable antipsychotics was compared. Studies and meta-analyses comparing long-acting-injectable antipsychotics vs placebo and vs oral antipsychotics across different study designs was critically reviewed. Adverse effects of long-acting-injectable antipsychotics and their potential for use early during the illness course was examined. Finally, arguments for and against long-acting-injectable antipsychotics as well as ways to effectively present and offer long-acting-injectable antipsychotics to patients with schizophrenia was described.
For more information on our Program, electronic copies of our best practice psychotherapeutic medication guidelines, and other resources visit our website floridabhcenter....